Benlysta 200 mg solution for injection in pre-filled pen. clinical trials

A Multi-Center, Open-Label Trial to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Subcutaneously Administered Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Participants with Systemic Lupus Erythematosus (SLE)

This study is looking at a medicine called Benlysta for children and young people with lupus. It wants to see how the body handles the medicine and if it's safe. This is an early study to learn more about this treatment in younger patients.